SE0201726D0 - New method and composition - Google Patents

New method and composition

Info

Publication number: SE0201726D0
Authority: SE; Sweden
Prior art keywords: allogeneic; antigen; cellular; pulsing; apc
Prior art date: 2002-06-06

Application number

SE0201726A

Other languages

English (en)

Other versions

SE523515C2 (sv

SE0201726L (sv

Inventor

Alex Karlsson-Parra

Annacarin Wallgren

Bengt Andersson

Original Assignee

Alex Karlsson Parra

Annacarin Wallgren

Bengt Andersson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-06

Filing date

2002-06-06

Publication date

2002-06-06

2002-06-06 Application filed by Alex Karlsson Parra, Annacarin Wallgren, Bengt Andersson filed Critical Alex Karlsson Parra

2002-06-06 Priority to SE0201726A priority Critical patent/SE523515C2/sv

2002-06-06 Publication of SE0201726D0 publication Critical patent/SE0201726D0/sv

2003-06-05 Priority to SI200332043T priority patent/SI1509244T1/sl

2003-06-05 Priority to EP03730977A priority patent/EP1509244B1/en

2003-06-05 Priority to AT03730977T priority patent/ATE517633T1/de

2003-06-05 Priority to AU2003241252A priority patent/AU2003241252A1/en

2003-06-05 Priority to ES03730977T priority patent/ES2369077T3/es

2003-06-05 Priority to US10/516,915 priority patent/US20050158328A1/en

2003-06-05 Priority to PCT/SE2003/000936 priority patent/WO2003103707A1/en

2003-06-05 Priority to DK03730977.0T priority patent/DK1509244T3/da

2003-12-07 Publication of SE0201726L publication Critical patent/SE0201726L/sv

2004-04-27 Publication of SE523515C2 publication Critical patent/SE523515C2/sv

2006-11-24 Priority to US11/603,819 priority patent/US8673296B2/en

2014-01-27 Priority to US14/164,518 priority patent/US20140141046A1/en

Links

239000000203 mixture Substances 0.000 title abstract 2
230000000735 allogeneic effect Effects 0.000 abstract 5
210000000612 antigen-presenting cell Anatomy 0.000 abstract 4
230000001413 cellular effect Effects 0.000 abstract 3
229960005486 vaccine Drugs 0.000 abstract 3
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
238000012258 culturing Methods 0.000 abstract 2
230000004927 fusion Effects 0.000 abstract 2
208000015181 infectious disease Diseases 0.000 abstract 2
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 2
238000001890 transfection Methods 0.000 abstract 2
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
208000025113 myeloid leukemia Diseases 0.000 abstract 1
201000000050 myeloid neoplasm Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SE0201726A 2002-06-06 2002-06-06 Ny metod och komposition för framställning av ett cellulärt allogent vaccin SE523515C2 (sv)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
SE0201726A SE523515C2 (sv)	2002-06-06	2002-06-06	Ny metod och komposition för framställning av ett cellulärt allogent vaccin
DK03730977.0T DK1509244T3 (da)	2002-06-06	2003-06-05	Ny fremgangsmåde og præparat til at producere en cellulær allogen vaccine
AU2003241252A AU2003241252A1 (en)	2002-06-06	2003-06-05	New method and composition for producing a cellular allogeneic vaccine
EP03730977A EP1509244B1 (en)	2002-06-06	2003-06-05	New method and composition for producing a cellular allogeneic vaccine
AT03730977T ATE517633T1 (de)	2002-06-06	2003-06-05	Neues verfahren und zusammensetzung zur herstellung einer zellulären allogenen vakzine
SI200332043T SI1509244T1 (sl)	2002-06-06	2003-06-05	Nov postopek in spojina za izdelavo celične alogenične vakcine
ES03730977T ES2369077T3 (es)	2002-06-06	2003-06-05	Nuevo procedimiento y composición para producir una vacuna alogénica celular.
US10/516,915 US20050158328A1 (en)	2002-06-06	2003-06-05	Method and composition for producing a cellular allogeneic vaccine
PCT/SE2003/000936 WO2003103707A1 (en)	2002-06-06	2003-06-05	New method and composition for producing a cellular allogeneic vaccine
US11/603,819 US8673296B2 (en)	2002-06-06	2006-11-24	Method and composition for producing a cellular allogeneic vaccine
US14/164,518 US20140141046A1 (en)	2002-06-06	2014-01-27	Method and composition for producing a cellular allogeneic vaccine

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0201726A SE523515C2 (sv)	2002-06-06	2002-06-06	Ny metod och komposition för framställning av ett cellulärt allogent vaccin

Publications (3)

Publication Number	Publication Date
SE0201726D0 true SE0201726D0 (sv)	2002-06-06
SE0201726L SE0201726L (sv)	2003-12-07
SE523515C2 SE523515C2 (sv)	2004-04-27

Family

ID=20288098

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0201726A SE523515C2 (sv)	2002-06-06	2002-06-06	Ny metod och komposition för framställning av ett cellulärt allogent vaccin

Country Status (1)

Country	Link
SE (1)	SE523515C2 (sv)

2002
- 2002-06-06 SE SE0201726A patent/SE523515C2/sv not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE523515C2 (sv)	2004-04-27
SE0201726L (sv)	2003-12-07

Similar Documents

Publication	Publication Date	Title
Filgueira et al.	1996	Human dendritic cells phagocytose and process Borrelia burgdorferi
ES2261250T3 (es)	2006-11-16	Celulas sdupresoras para prevencion y tratamiento de respuestas inmunes en trasplantes.
WO2004096975A3 (en)	2005-03-10	Apparatus and methods for amplification of blood stem cell numbers
ATE367833T1 (de)	2007-08-15	IN-VITRO-VERFAHREN ZUM HERSTELLEN EINER HOMOLOGEN ßGESTENTETENß TISSUE ENGINEERTEN HERZKLAPPE
JP2019531744A5 (sv)	2020-12-03
SI1509244T1 (sl)	2011-11-30	Nov postopek in spojina za izdelavo celične alogenične vakcine
IL248493A0 (en)	2016-11-30	A method for increasing type 1 presentation of exogenous antigens using dendritic cells of human origin
MXPA02007137A (es)	2004-09-06	Fuente de tejido hepatico.
WO2005007799A3 (en)	2005-03-03	Methods for ex-vivo expanding stem/progenitor cells
WO2004053072A3 (en)	2005-06-16	Administration of dendritic cells partially matured in vitro for the treatment of tumors
DK1634949T3 (da)	2011-03-28	Fremgangsmåde til at generere aktiverede T-celler og antigen-inkuberede antigen-præsenterende celler
ZA200301466B (en)	2004-02-24	Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells.
MXPA05006350A (es)	2006-02-08	Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones.
DE60213852D1 (de)	2006-09-21	Herstellung von zellsuspensionen
BR0211491A (pt)	2004-08-17	Geração de células dendrìticas totalmente madura e estáveis de produtos de leucafereses para aplicações clìnicas
US6703016B1 (en)	2004-03-09	Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
DE60032508D1 (de)	2007-02-01	VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN
ATE512668T1 (de)	2011-07-15	Allogenes tumortherapeutikum
Malone et al.	2001	Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer
Mohty et al.	2002	Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts
Royer et al.	2006	Culture medium and protein supplementation in the generation and maturation of dendritic cells
Westermann et al.	2003	Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties
DK1419240T3 (da)	2011-10-17	Fremstilling og anvendelse af humane CD124- og CD116-positive tumorcellelinier til fremstilling af allogene eller semi-allogene immumterapeutika
Nguyen et al.	2002	Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients
SE0201726L (sv)	2003-12-07	Ny metod och komposition

Legal Events

Date	Code	Title	Description
2021-10-05	NUG	Patent has lapsed